As aging is a major risk factor for the development of AD, downregulation of Willin/FRMD6 in response to Aβ may represent a pathological facet of previous observations of decreased Willin/FRMD6 expression with cellular and organismal aging [11]. This evidence concerns the gene FRMD6 and Alzheimer disease.